• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

Probiotic blends containing L. acidophilus DDS-1 offer condition-specific results

Chiropractic Economics May 18, 2010

May 18, 2010 — Premium Probiotic Blends containing the super strain, Lactobacillus acidophilus DDS-1 have demonstrated condition-specific health benefits. 

A recent clinical case study demonstrated the effectiveness of the probiotic blend containing L. acidophilus DDS-1, Bifidobacterium longum, Bifidobacterium lactis and Bifidobacterium bifidum in treating irritable bowel syndrome (IBS). 

A clinical study published last year demonstrated effectiveness of the L. acidophilus DDS-1, B. lactis blend in reducing the symptoms of atopic dermatitis in young children. 

The health attributes of L. acidophilus DDS-1 have been well documented and include:

• Human isolates that adapt well to the human body

• Acid and bile resistance that make it well-suited for intestinal survival

• Ability to promote digestive health

• Creates an unfavorable environment for pathogens

• Maintains natural immune defenses

• Contributes to good balance of intestinal flora

Lactobacillus acidophilus DDS-1 is a unique endogenous human isolate extensively researched and protected by U.S. patent and Trademark and manufactured and marketed by UAS Laboratories Inc.

Since 1979, L. acidophilus DDS-1 strain has been marketed worldwide as an effective probiotic strain. It has been the subject of a variety of in vitro, human and animal studies for more than 40 years. 

The focus of the efficacy research on this strain has been on its nutritional, antibacterial, antipathogenic, anticarcinogenic and antiallergic properties. The antibacterial substance, acidophilin, produced by L. acidophilus DDS-1, has been demonstrated to inhibit more than 26 different pathogenic strains.

Lactobacillus acidophilus DDS-1 is available as a high count freeze-dried material taking advantage of UAS Laboratories’ latest stability innovation. This probiotic superstrain is suitable for applications in dietary supplements, food and beverages. 

Four tested blends containing L. acidophilus DDS-1 are now available:

1. DDS Probiotic Blend No. 1 containing L. acidophilus DDS-1, Bifidobacterium longum plus FOS (5 billion CFU/gram)

2. DDS Probiotic Blend No. 2 containing L. acidophilus DDS-1, B. lactis plus FOS (5 billion CFU/gram)

3. DDS Probiotic Blend No. 3 containing L. acidophilus DDS-1, B. longum, B. lactis, B. bifidum plus FOS (10 billion CFU/gram)

4. DDS Probiotic Blend No. 4 containing Lactobacillus acidophilus DDS-1 plus FOS (fructooligosaccharides) – 5 billion CFU/gram

Source: UAS Laboratories, www.uaslabs.com

Related Posts

  • Nutra Research offers complete joint supplementNutra Research offers complete joint supplement
  • Post-purification program available from Standard ProcessPost-purification program available from Standard Process
  • Survey: Patients report inability to access own medical  records as top concernSurvey: Patients report inability to access own medical records as top concern
  • UAS Laboratories receives Kosher Certification for all DDS ProbioticsUAS Laboratories receives Kosher Certification for all DDS Probiotics
  • Study: probiotic supplementation reduces atopic dermatitisStudy: probiotic supplementation reduces atopic dermatitis
  • Standard Process introduces Cellular VitalityStandard Process introduces Cellular Vitality

Filed Under: Industry News, News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Sherman College named school of national service by AmeriCorps
    Sherman College logo
  • New Mentor Program for Black Hemp Farmers Announced by CBD Leader Charlotte’s Web
  • Foot Levelers announces new orthotic training sessions, speakers
x